Isomorphic Labs, a DeepMind spin-off, applies AI to revolutionize drug discovery. By modeling molecular interactions with unprecedented precision, it accelerates the identification of promising drug candidates. This benefits pharmaceutical companies, researchers, and ultimately patients, by slashing development timelines and costs, making new, effective treatments more accessible.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends